Essilor International (ESLOY) Lifted to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Essilor International (OTCMKTS:ESLOY) from a sell rating to a hold rating in a report released on Friday.

According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “

Separately, Royal Bank Of Canada started coverage on shares of Essilor International in a research note on Thursday, September 21st. They set an underperform rating for the company.

Essilor International (ESLOY) opened at $66.86 on Friday. The company has a quick ratio of 0.76, a current ratio of 1.09 and a debt-to-equity ratio of 0.27. Essilor International has a 12 month low of $51.71 and a 12 month high of $68.43.

TRADEMARK VIOLATION WARNING: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/05/essilor-international-esloy-lifted-to-hold-at-zacks-investment-research.html.

About Essilor International

Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is a France-based ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals.

Get a free copy of the Zacks research report on Essilor International (ESLOY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Essilor International SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International SA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply